OXYGENTA PHARMACEUTICAL
Back to Income Statement
|
OXYGENTA PHARMACEUTICAL Last 5 Year Revenue History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹113 Cr | ₹109 Cr | ₹40 Cr | ₹31 Cr | ₹61 Cr |
What is the latest Revenue of OXYGENTA PHARMACEUTICAL ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹113 Cr |
| Mar2025 | ₹109 Cr |
| Mar2024 | ₹40 Cr |
| Mar2023 | ₹31 Cr |
| Mar2022 | ₹61 Cr |
How is Revenue of OXYGENTA PHARMACEUTICAL Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹113 Cr | 3.37 | |
| Mar2025 | ₹109 Cr | 175.72 | |
| Mar2024 | ₹40 Cr | 27.93 | |
| Mar2023 | ₹31 Cr | -48.80 | |
| Mar2022 | ₹61 Cr | - | |
Compare Revenue of peers of OXYGENTA PHARMACEUTICAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| OXYGENTA PHARMACEUTICAL | ₹236.2 Cr | -5.3% | 32.3% | -28.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,090.0 Cr | 1% | -2.7% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,976.0 Cr | 0.7% | 17.1% | 40.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,639.0 Cr | -0.3% | -3.7% | 37.9% | Stock Analytics | |
| CIPLA | ₹115,216.0 Cr | -0.3% | 2.3% | -8.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.4 Cr | -1.4% | 0.7% | -6.2% | Stock Analytics | |
OXYGENTA PHARMACEUTICAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| OXYGENTA PHARMACEUTICAL | -5.3% |
32.3% |
-28.1% |
| SENSEX | -0.6% |
1% |
-3.7% |
You may also like the below Video Courses